Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain

Cell Mol Neurobiol. 2020 Jul;40(5):751-764. doi: 10.1007/s10571-019-00770-9. Epub 2019 Dec 20.

Abstract

Pigment epithelium-derived factor (PEDF) is a neurotrophic factor with neuroprotective, antiangiogenic, and antipermeability effects. In the brain, blood-brain barrier (BBB) function is essential for homeostasis. Its impairment plays a crucial role in the pathophysiology of many neurological diseases, including ischemic stroke. We investigated (a) whether PEDF counteracted vascular endothelial growth factor (VEGF)-induced BBB disruption in the mouse brain, (b) the time course and route of BBB permeability and the dynamics of PEDF expression after cerebral ischemia, and (c) whether intraventricular infusion of PEDF ameliorated brain ischemia by reducing BBB impairment. C57Bl6/N mice received intraparenchymal injections of CSF, VEGF, or a combination of VEGF and PEDF. PEDF increased paracellular but not transcellular BBB integrity as indicated by an increase in the tight junction protein claudin-5. In another group of mice undergoing 60-min middle cerebral artery occlusion (MCAO), transcellular BBB permeability (fibrinogen staining in the absence of a loss of claudin-5) increased as early as 6 h after reperfusion. PEDF immunofluorescence increased at 24 h, which paralleled with a decreased paracellular BBB permeability (claudin-5). PEDF after MCAO originated from the blood stream and endogenous pericytes. In the third experiment, the intraventricular infusion of PEDF decreased edema and cell death after MCAO, potentially mediated by the improvement of the paracellular route of BBB permeability (claudin-5) in the absence of an amelioration of Evans Blue extravasation. Together, our data suggest that PEDF improves BBB function after cerebral ischemia by affecting the paracellular but not the transcellular route. However, further quantitative data of the different routes of BBB permeability will be required to validate our findings.

Keywords: Blood–brain barrier; Cerebral ischemia; Claudin-5; Fibrinogen; MCAO; Pigment epithelium-derived factor.

MeSH terms

  • Animals
  • Blood-Brain Barrier / drug effects*
  • Blood-Brain Barrier / injuries
  • Blood-Brain Barrier / metabolism
  • Claudin-5 / metabolism
  • Disease Models, Animal
  • Eye Proteins / pharmacology*
  • Eye Proteins / therapeutic use
  • Ischemic Attack, Transient / metabolism
  • Ischemic Attack, Transient / therapy*
  • Mice
  • Mice, Inbred C57BL
  • Nerve Growth Factors / pharmacology*
  • Nerve Growth Factors / therapeutic use
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Serpins / pharmacology*
  • Serpins / therapeutic use
  • Vascular Endothelial Growth Factor A / pharmacology

Substances

  • Claudin-5
  • Eye Proteins
  • Nerve Growth Factors
  • Neuroprotective Agents
  • Serpins
  • Vascular Endothelial Growth Factor A
  • pigment epithelium-derived factor